Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?23.48
 
WKN: A3D38K / Symbol: FWBI / Name: First Wave BioPharma / Stock / Pharmaceuticals / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

First Wave BioPharma Inc. Stock

The community is currently still undecided about First Wave BioPharma Inc. with 2 Buy predictions and 0 Sell predictions.
With a target price of 23 € there is potential for a 482.57% increase which would mean more than doubling the current price of 3.95 € for First Wave BioPharma Inc..
Our community identified positive and negative aspects for First Wave BioPharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the First Wave BioPharma Inc. stock. On the other hand our users think that "EBIT growth" could be a problem in the future.

Pros and Cons of First Wave BioPharma Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -
Target price 36.676
Change
Ends at 03.01.25

First Wave BioPharma, Inc. (NASDAQ: FWBI) had its price target raised by analysts at Roth Mkm from $11.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for FWBI provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.00%
Target price 10.293
Change
Ends at 19.09.24

First Wave BioPharma, Inc. (NASDAQ: FWBI) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $11.00 price target on the stock.
Ratings data for FWBI provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 677.78%
Target price 17.010
Change
Ends at 09.03.24

First Wave BioPharma, Inc. (NASDAQ: FWBI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Ratings data for FWBI provided by MarketBeat
Show more